Effects of competitive and noncompetitive antagonists of the N-methyl-D-aspartate receptor on the analgesic action of delta(1)- and delta(2)-opioid receptor agonists in mice

被引:13
作者
Bhargava, HN
Zhao, GM
机构
[1] Dept. Pharmaceut. and Pharmacodyn., University of Illinois at Chicago, Health Sciences Center, Chicago, IL 60612
关键词
delta-Opioid receptor agonists; analgesia; NMDA receptor antagonists; MK-801; LY; 235959; H-3]-[D-Pen(2); D-Pen(5)]enkephalin; ([H-3]-DPDPE); binding;
D O I
10.1111/j.1476-5381.1996.tb16076.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects of MK-801, a noncompetitive antagonist of the N-methyl-D-aspartate (NMDA) receptor and LY 235959, a competitive antagonist of the NMDA receptor on the analgesic actions of [D-Pen(2),D-Pens]enkephalin (DPDPE) and [D-Ala(2), Glu(4)] deltorphin II (deltorphin II), the putative delta(1)- and delta(2)-opioid receptor agonists, respectively, were determined in the male Swiss-Webster mice. 2 Intracerebroventricular administration of DPDPE or deltorphin II produced analgesia. MK-801 administered intraperitoneally 10 min before the injection of DPDPE or deltorphin II, dose-dependently antagonized the analgesic actions of both drugs. 3 LY 235959 also dose-dependently antagonized the analgesic actions of DPDPE and deltorphin II. 4 The effects of MK-801 and LY 235959 on the binding of [H-3]-DPDPE to mouse brain membranes were also determined. Neither of the NMDA receptor antagonists had any effect on the binding of [H-3]-DPDPE. 5 It is concluded that competitive and noncompetitive antagonists of the NMDA receptor antagonize the analgesic action of delta(1)- and delta(2)-opioid receptor agonists and that such effects are not mediated via a direct interaction with brain delta-opioid receptors.
引用
收藏
页码:1586 / 1590
页数:5
相关论文
共 28 条
[1]  
AANONSEN LM, 1987, J PHARMACOL EXP THER, V243, P9
[2]   DIZOCILPINE (MK-801) BLOCKS TOLERANCE TO THE ANALGESIC BUT NOT TO THE HYPERTHERMIC EFFECT OF MORPHINE IN THE RAT [J].
BHARGAVA, HN ;
MATWYSHYN, GA .
PHARMACOLOGY, 1993, 47 (06) :344-350
[3]  
BHARGAVA HN, 1994, PHARMACOL REV, V46, P293
[4]  
BHARGAVA HN, 1995, PHARMACOLOGY, V51, P323
[5]  
D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74
[6]  
GOODCHILD CS, 1993, ANAESTHETIC PHARM RE, V2, P184
[7]  
GREENAMYRE JT, 1984, J NEUROSCI, V4, P2133
[8]   PHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSE [J].
HALEY, TJ ;
MCCORMICK, WG .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1957, 12 (01) :12-15
[10]  
JIANG Q, 1991, J PHARMACOL EXP THER, V257, P1069